Our platform interrogates small RNA to identify mutations that drive disease
AI-POWERED PLATFORM ACCELERATES DISCOVERY AND DESIGNS MORE EFFECTIVE DRUGS
BIOLOGY INFLUENCED MACHINE LEARNING IDENTIFIES SMALL RNA MUTATIONS THAT ARE SHARED BETWEEN GROUPS OF PATIENTS WITHIN A DISEASE INDICATION
Platform analyzes millions of sRNA features to identify mutations that :
- Classifies disease
- Stratifies subjects
- Predicts disease drivers
- Designs RNA therapeutics
OLIGONUCLEOTIDES TARGETING EFFECTS OF SRNA MUTATIONS A NEW CLASS OF RNA THERAPEUTICS
sRNA therapeutics are delivered using lipid nanoparticles and conjugates
High fidelity therapeutics targeting sRNA mutations enable unmatched precision
Advancements in lipid nanoparticle and conjugate chemistry enable drug delivery to specific tissue
SEMANTIC KNOWLEDGE GRAPH DISCOVERS COMMON MUTATIONS ACROSS DISEASE INDICATIONS
Discover novel drugs that treat multiple indications
Repurpose existing compounds including small molecules, protacs, mabs
Introduce new combinational therapies
